Economic evaluation in the field of cardiology: Theory and practice

Progress in Cardiovascular Diseases

Volumn 42, Issue 2, 1999, Pages 167-173

  Van Hout, B A ^a   Goes, E S ^a   Grijseels, E W M ^a   Van Ufford, M A Q ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLOGY; CORONARY ARTERY DISEASE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; COST UTILITY ANALYSIS; ECONOMIC EVALUATION; MEDICAL CARE; QUALITY ADJUSTED LIFE YEAR; REVIEW; THEORY;

EID: 0032749279     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-0620(99)70016-2     Document Type: Article

References (25)

1. Nederlandse Hartstichting. Hart en Vaatziekten in Nederland 1997 Cijfers over ziekte en sterfte 1997 Den Haag The Netherlands
2. B Hout G Bonsel D Habbema Heart transplantation in the Netherlands: Costs, effects and scenarios J Health Economics 12 1993 73 93
3. EFD Wever RNW Hauer G Schrijvers Cost-effectiveness of implantable defribrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors: A randomized study Circulation 93 1996 489 495
4. RA Henderson Long-term results of RITA-1 trial: Clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina Lancet 352 1998 1419 1425
5. MJ de Boer BA van Hout AL Liem A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction Am J Cardiol 76 1995 830 833
6. PW Serruys P de Jaegere F Kiemeneij A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease N Engl J Med 331 1994 489 495
7. BA van Hout T van der Woude PPT de Jaegere Cost effectiveness of stent implantation versus PTCA: The BENESTENT experience Semin Intervent Cardiol 1 1996 263 268
8. M Johannesson B Jönsson J Kjekshus Cost-effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease N Engl J Med 336 1997 332 336
9. B Jönsson M Johannesson J Kjekshus Cost-effectiveness of cholesterol lowering: Results from the Scandinavian Simvastatin Survival Study (4S) Eur Heart J 17 1996 1001 1007
10. LL Martens The cost-effectiveness of cholesterol-lowering therapy with simvastatin in the primary prevention of coronary heart disease in the Netherlands 1992 Thesis, Erasmus University Rotterdam, The Netherlands
11. BC Michel MJ Al WJ Remme Economic aspects of treatment with captopril for patients with asymptomatic left ventricular dysfunction in the Netherlands Eur Heart J 17 1996 731 740
12. BA van Hout G Wielink GJ Bonsel Effects of ACE inhibitors on heart failure in the Netherlands: A pharmacoeconomic model PharmacoEconomics 3 1993 387 397
13. BA van Hout ML Simoons Costs and effects of c7E3 in high risk PTCA patients: An indirect analysis for the Netherlands Eur Heart J 16 suppl L 1995 81 85
14. DB Mark JD Talley EJ Topol Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty Circulation 94 1996 629 635
15. DB Mark MA Hlatky RM Califf Cost effectiveness of thrombolytic therapy with plasminogen activators as compared with streptokinase for acute myocardial infarction N Engl J Med 332 1995 1418 1424
16. MF Drummond B O'Brien GL Stoddart Methods for the Economic Evaluation of Health Care Programmes ed 2 1997 Oxford University Press York, UK
17. HE Klarman JO Fransis GD Rosenthal Cost effectiveness analysis applied to the treatment of chronic renal disease Med Care 6 1968 48 54
18. PFMM van Bergen JJC Jonker BA van Hout Costs and effects of long-term oral anticoagulant treatment after myocardial infarction JAMA 273 1995 925 928
19. Scandinavian Simvastatin Survival Study Group Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
20. FM Sacks MA Pfeffer LA Moye The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels N Engl J Med 335 1996 1001 1009
21. J Shepherd SM Cobbe I Ford Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia N Engl J Med 333 1995 1301 1307
22. BA van Hout L Bowman DJ Zelinger Costs and effects in therapy for acute coronary syndromes: The case of abciximab in high-risk patients undergoing percutaneous transluminal coronary angioplasty in the EPIC study Am Heart J 135 1998 S98 S106
23. ML Simoons AF Casparie Behandeling en preventie van coronaire hartziekten door verlaging van deserumcholesterolconcentratie; Derde consensus ‘Cholesterol.’ Ned Tijdschr v Geneeskd 142 1998 2083 2086
24. M Berg Rationalizing medical work: Decision support techniques and medical practices 1995 Thesis, Rijksuniversiteit Limburg Maastricht, The Netherlands
25. E de Bruijn NS Klazinga RJM Dillman “Passend kiezen in de gezondheidszorg?” (More information on the project Appropriate medical Care, in Dutch) Medisch Contact 53 1998 586 589